FDA rejects AcelRx's request for meeting on pain drug device

Reuters: AcelRx Pharmaceuticals Inc said a division of the U.S. Food and Drug Administration had rejected the company's request for a meeting to discuss the need for an additional trial of its pain drug device, Zalviso.

Read article